beta-alanine has been researched along with Hospital-Acquired Condition in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"dabigatran (Pradaxa®) is a direct and specific thrombin inhibitor." | 2.49 | [General characteristics of the new oral anticoagulants]. ( Berrut, G; Chevalet, P; De Decker, L; Gegu, M; Piloquet, FX, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gegu, M | 1 |
Chevalet, P | 1 |
Piloquet, FX | 1 |
Berrut, G | 1 |
De Decker, L | 1 |
1 review available for beta-alanine and Hospital-Acquired Condition
Article | Year |
---|---|
[General characteristics of the new oral anticoagulants].
Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabig | 2013 |